Plunkett Research Online: Agenus Inc

AGENUS INC (AGEN:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Agenus, Inc. is a clinical-stage immuno-oncology (I-O) company focused on the discovery and development of therapies that engage the body’s immune system to fight cancer. The company pursues single agent and combination approaches that leverage antibody therapeutics, proprietary cancer vaccine plat.....



Agenus Inc
Ticker: AGEN
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 781 674-4400
Fax: 781 674-4200
Address: 3 Forbes Road
Lexington, MA 02421-7305 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Cancers & Infectious Diseases Products & Technologies
ContactsDescription
Garo ArmenCEO/Chairman of the Board/Director/Founder
Christian CortisCFO/Chief Strategy Officer/Other Corporate Officer
See More
Agenus, Inc. is a clinical-stage immuno-oncology (I-O) company focused on the discovery and development of therapies that engage the body’s immune system to fight cancer. The company pursues single agent and combination approaches that leverage antibody therapeutics, proprietary cancer vaccine plat.....See More See More

Auditor: KPMG LLP
Legal Advisor: Choate, Hall & Stewart LLP
$USD, In whole numbers,
except marked * or %
201820172016201520142013
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Prophage
AutoSynVax
PhosphoSynVax
QS-21 Stimulon
AgenTus Therapeutics Inc
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: